Pattern Recognition and Anomaly Detection in Fetal Morphology Using Deep Learning and Statistical Learning

Launched by UNIVERSITY OF CRAIOVA · Feb 11, 2023

Keywords

ClinConnect Summary

This clinical trial, called PARADISE, is studying a new way to detect congenital abnormalities (CA) in unborn babies. Congenital abnormalities are problems that are present at birth and can lead to serious health issues or even death. The goal of this trial is to develop a smart system that uses advanced technology to improve the accuracy of Morphology Scans, which are special ultrasounds that help doctors see if a baby has any abnormalities before birth. By detecting these issues early, healthcare providers can better plan for medical care right after the baby is born, potentially saving lives and reducing health problems.

To participate in this trial, you need to be a pregnant woman in your second trimester. The study is currently recruiting participants, and your involvement could help improve healthcare for future generations. If you join, you can expect to undergo additional testing that aims to enhance the way doctors interpret ultrasound results. This innovative approach not only aims to better support parents by providing clearer information about their baby's health but also contributes to advancements in medical technology and care practices.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Second trimester pregnant women
• Exclusion Criteria:
• • -